Posts

Researchers Receive $1 Million Grant to Study Digital Screening Intervention Tool for Adolescents and Young Adults

cliexa is excited to partner with the University of Northern Colorado (UNC) with a grant from the Department of Health and Human Services’ Office of Adolescent Health that provides nearly one million dollars over the next two years for the implementation of cliexa-OPTIONS, a digital screening intervention tool that fosters earlier identification of high-risk adolescents in a clinical setting. The funding supports independent evaluation including, cost-benefit analysis and randomized controlled trial of the cliexa-OPTIONS risk screening tool and MyPLAN mobile health follow-up. The Principal Investigator for the project at UNC is Dr. William Merchant. He is the evaluation professor in the Applied Statistics and Research Methods program in the College of Education and Behavioral Sciences. 

The cost-benefit analysis assesses cost savings between the cliexa-OPTIONS risk screening against current paper pencil and verbal screenings. Also, the cliexa-OPTIONS risk screening identifies 30- 50% more risk in adolescent populations fostering early identification of adolescents at highest risk for acquiring an STI or experiencing an unplanned pregnancy. Improving quality in clinical workflows for adolescent and young adult populations is timely, given that sexually transmitted infections for young people ages 15 -24 are at epidemic proportions.

Saving time and keeping providers satisfied with new technology in clinical workflows is no simple task. The cost-benefit analysis will also assess the benefits of early identification of adolescents at highest risk for adverse reproductive health outcomes, substance use, mental health, and wellness.

Read the full article at: //www.unco.edu/news/newsroom/releases/million-dollar-grant-digital-screening-intervention-tool.aspx

Image of the White House Lawn

cliexa’s hard work and commitment to improving our country’s healthcare systems has been recognized by the Office of American Innovation (OAI) for our advancements within the industry. The OAI, appointed by President Donald J. Trump, and led by Jared Kushner, has invited cliexa to attend the 2019 White House Blue Button Developers Conference in Washington, D.C. on Tuesday, July 30th at the Eisenhower Executive Office Building. We are humbled and honored to receive this invitation. We are looking forward to connecting and potentially collaborating with policymakers, technologists, and medical experts to advance the sharing of medical information through mobile technology.

We are one of the few technology vendors who have successfully enabled the Center for Medicare and Medicaid’s (CMS) Blue Button 2.0 API into our software platforms. According to CMS’s website, the Blue Button 2.0 API is a “developer-friendly, standards-based API that enables Medicare beneficiaries to connect their claims data to the applications, services and research programs they trust.” This API enables patients to sync their Medicare accounts to our applications and bi-directionally share the information, specifically claims data, to their providers, and care teams.

With this information, there are a variety of potential outcomes from leveraging this data, including streamlined documentation and the secure exchange of patient information which can lead to uncovering new insights about patients’ health status and increasing time for face-to-face interactions between patient and provider.

Image of cliexa-EASE with CMS' Blue Button 2.0 API enabled

Our first use case for this API was in our application, cliexa-EASE, designed for the Department of Health and Human ServicesAgency for Healthcare Research and Quality‘s Step-Up App Challenge. With this build, we were selected as one of the three winners of this challenge. The goal of the challenge was to develop an application that simplifies the process of collecting, interpreting, aggregating and sharing patient-reported outcomes (PRO) data related to physical function outcomes. Using the Blue Button 2.0 API, patients could connect Medicare accounts to our platform and share their claims data directly to the health systems’ electronic medical record system. Other functionalities including the connection and aggregation of data from IoT and wearable devices, electronic medical record systems paired with custom, mobile clinical assessments.

To learn more about the Blue Button 2.0 API, and the Blue Button Developers Conference, visit //bluebutton.cms.gov/

Image of the "Best Rheumatoid Arthritis Apps 2019" from Healthline Media
Image of the "Best Rheumatoid Arthritis Apps 2019" from Healthline Media

In a late May article by Healthline, cliexa-RA was named one of the “Best Rheumatoid Arthritis Apps of 2019.” For the second straight year, cliexa-RA has been nominated for this selection, receiving a perfect five stars on the iOS App Store and the highest average score among all apps named. With the extensive features, assessments, accuracy, and patient-physician efficiency included with the application, it is one of the most thorough rheumatoid arthritis apps on the market.

cliexa-RA is a specially designed app for tracking patient progress, medication adherence, and complications from the patient’s smartphone. It includes several medically validated and custom assessments for keeping tabs on patients and providing physicians with accurate and up-to-date information. The app can also use a patient’s medical history and statistical data to more clearly assess patients\’ rheumatoid arthritis progress and therefore help physicians accurately provide treatment plans. The outpatient data helps create efficiency of communication between patient and physician, cutting down on time spent at the clinic and providing more accurate care solutions.

cliexa’s platform implements effective Remote Patient Monitoring to optimize clinical workflow, medical billing compliance, and reimbursements. Accurate outpatient data is essential to the cliexa platform, with cliexa-RA being recognized for its capability to utilize Remote Patient Monitoring effectively.

Read More: The Best Rheumatoid Arthritis Apps of 2019

Previous: The Best Rheumatoid Arthritis Apps of 2018

The Silicon Review's 30 Best Leaders to Watch in 2019

cliexa’s Founder and CEO, Mehmet Kazgan, is rated as one of the “30 Best Leaders to Watch in 2019” Mehmet was featured in an article highlighting his success as an entrepreneur, and business owner. Mehmet founded cliexa in late 2015 and has been working diligently to grow the company. Mehmet sat down with the Silicon Review team to discuss his experience as a leader in business, and healthcare technology.

Here is a snippet from the article:

“What is your greatest fear, and how do you manage fear?”

“My greatest fear is to over-promise and under-deliver, in any form, within a business or non-business related context. I manage fear by acknowledging it and facing it when the time comes.”

“What were the biggest initial hurdles to building your business and how did you overcome them?”

“Convincing others about my entrepreneurial approach and vision was one of the biggest hurdles. Validating the concept and demonstrating the outcomes was one of the ways I worked to overcome them.”

To read the full article, click HERE.

In 2018, cliexa was selected as one of Jumpstart Foundry’s portfolio companies. Jumpstart recognizes the value of recent healthcare industry trends including “Remote Patient Monitoring” and “Telehealth.” In their recent article, JSF featured cliexa in their discussion of these recent technological trends in healthcare.

One of the key challenges in healthcare that we are solving is being able to render results interpretable to patients and providers, while creating efficient, streamlined communication and workflow. cliexa’s Remote Monitoring platforms assist providers in making more informed decisions about treatment plans and enable them to respond more quickly to new data so their patients will have fewer complications or side effects. cliexa suite of products enables providers to deliver value-based care which translates to significant cost savings.

With clinically validated scoring models, our platform provides clinicians multiple reference points with correlations to identify the accuracy of patient reported data which will result in better patient and clinician experience and enables more responsive and preventive treatments.

Patients will play a greater role in their care with cliexa and will be able to make valuable correlations to causative factors for pain flare-ups through remotely reported outcomes. The discrete clinical data and patient-reported outcomes enable providers to improve clinical decision making, while reducing liability and billing concerns with payors. These algorithms help providers respond more efficiently to new data so their patients will have fewer complications or side effects.

Click here to learn more about cliexa’s Digital Solutions for Healthcare.